Dr Begoña Alcaraz, gynaecologist at Instituto Bernabeu Alicante, addresses maternity and the challenges of reproductive medicine in “Suavinex Out Loud”
January, 9th 2024
In the last “Suavinex Out Loud” episode, a YouTube broadcast programme that openly addresses the challenges of motherhood and parenting, Dr Begoña Alcaraz, gynaecologist at Instituto Bernabeu Alicante, explained the different reasons why some women face difficulties in conceiving and the options they have available to become mothers thanks to reproductive medicine.
The Customer Service and Back Office Head at Suavinex, Lorena Monzó, conducted the interview focused on providing a clear view on the treatment options available to women who wish to have children but encounter obstacles on their path to motherhood.
Dr Alcaraz shared her professional perspective, stressing that “there are different treatment options available, and the most appropriate one for each patient will be recommended after an individual study”. This personalised approach reflects Instituto Bernabeu’s commitment to providing solutions tailored to each person’s specific needs.
In the programme, Dr Alcaraz also addressed the changing social dynamics, noting that it is increasingly common to attend women in office without a partner or same-sex couples in their quest for motherhood. In this context, she stressed the importance of informing young women about all available options, breaking down stigmas and expanding the conception possibilities. “It is essential to inform young women of all the options they have available to plan their reproductive future. Until recently women were not properly informed and this greatly limits women’s chances of conceiving,” she pointed.
Dr Alcaraz also highlighted Instituto Bernabeu’s commitment to ongoing research in the field of fertility, especially in the area of genetics. “At Instituto Bernabeu we have a great team in charge of ongoing research in the field of fertility, especially in the world of genetics,” she said, underlining the institution’s commitment to innovation, individualisation and constant improvement of fertility treatments.